Literature DB >> 3455474

Relationship of nuclear magnetic resonance examinations to clinical data, cerebrospinal fluid findings and visual evoked potentials in multiple sclerosis.

D Uhlenbrock1, E Herbe, M Haupts.   

Abstract

We examined 150 patients with a 0.5 Tesla MR system. Fourteen patients were excluded from the study, because, in addition to the clinical signs of multiple sclerosis, they showed other abnormalities (spinal canal narrowing, embolic disease, Vitamin B12 deficiency, etc.). The results of the 136 examinations were related to the duration of disease, index of impairment on Kurtkze's disability scale, the clinical course, and the CSF and VEP results. The MR studies were evaluated in a semiquantitative manner. Patients with a long duration of disease demonstrated more changes than did cases with a short course. We found more periventricular confluences and more white matter plaques in the centrum semiovale. In addition, more lesions were seen in patients with a severe course of disease. All patients with negative CSF results (n = 13) showed positive MR examinations, and vice versa, patients with positive CSF findings showed negative MR results (n = 5). First results of a follow-up study demonstrate that most abnormalities in MR are not related to the clinical course or therapeutical procedure.

Entities:  

Mesh:

Year:  1987        PMID: 3455474     DOI: 10.1007/BF01782048

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  21 in total

1.  Magnetic resonance imaging in multiple sclerosis: results in 32 cases.

Authors:  J A Jackson; D R Leake; N J Schneiders; L A Rolak; G R Kelley; J J Ford; S H Appel; R N Bryan
Journal:  AJNR Am J Neuroradiol       Date:  1985 Mar-Apr       Impact factor: 3.825

2.  Magnetic resonance imaging of multiple sclerosis: a study of pulse-technique efficacy.

Authors:  V M Runge; A C Price; H S Kirshner; J H Allen; C L Partain; A E James
Journal:  AJR Am J Roentgenol       Date:  1984-11       Impact factor: 3.959

3.  Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis.

Authors:  R Troiano; M Hafstein; M Ruderman; P Dowling; S Cook
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

4.  Interval computed tomography in multiple sclerosis.

Authors:  M A Weinstein; R J Lederman; A D Rothner; P M Duchesneau; D Norman
Journal:  Radiology       Date:  1978-12       Impact factor: 11.105

5.  Multifocal CT enhancement in MS.

Authors:  G C Ebers; F V Vinuela; T Feasby; B Bass
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

6.  Acute multiple sclerosis with contrast-enhancing plaques.

Authors:  S Lebow; D C Anderson; A Mastri; D Larson
Journal:  Arch Neurol       Date:  1978-07

7.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

8.  Magnetic resonance demonstration of multiple sclerosis plaques in the cervical cord.

Authors:  K R Maravilla; J C Weinreb; R Suss; R L Nunnally
Journal:  AJR Am J Roentgenol       Date:  1985-02       Impact factor: 3.959

9.  [NMR tomography in confirmed multiple sclerosis. An assessment of 21 cases].

Authors:  D Uhlenbrock; E Dickmann; H K Beyer; W Gehlen
Journal:  Digitale Bilddiagn       Date:  1985-03

10.  Nuclear magnetic resonance (NMR) imaging in white matter disease of the brain using spin-echo sequences.

Authors:  I R Young; C P Randell; P W Kaplan; A James; G M Bydder; R E Steiner
Journal:  J Comput Assist Tomogr       Date:  1983-04       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.